🔎 Trials Near Me

Gara Jalqabaatti › Makroglobulinemiyaa Waldenstrom

Qorannoo klinikaalii Makroglobulinemiyaa Waldenstrom Ameerikaa Keessatti hirmaatuu

Qorannoo 30 Makroglobulinemiyaa Waldenstrom f bakka adda addaa Ameerikaa Keessatti hirmaatuu jiru.

Magaalota qorannoo baay'ee qaban

Naannoon

Qorannoo yeroo dhihootti haaromfaman

Takkalaa qorannoo (Ingiliffa)

A Dose-Escalation and Expansion Study of Tacabrutideg (BGB-16673) in Participants With B-Cell Malignancies

Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT05006716

ABBV-383 for the Treatment of Relapsed Refractory Waldenström Macroglobulinemia

Namoota walitti qabaa jiraSadarkaa 1/2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT07420959

Efficacy and Safety of Nemtabrutinib (MK-1026) in Participants With Hematologic Malignancies (MK-1026-003)

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 05-Onk-2026 · NCT04728893

A Study of Pirtobrutinib, Venetoclax, and Rituximab in People With Waldenström's Macroglobulinemia (WM)/Lymphoplasmacytic Lymphoma (LPL)

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ful-2026 · NCT07231952

A Study of LY4152199 in Participants With Previously Treated B-cell Malignancies (BAF_FRontier-1 )

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 22-Ful-2026 · NCT07101328

Zanubrutinib, Bendamustine, Rituximab Prev. Untreated WM

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Ful-2026 · NCT06561347

A Study of ARC-02 in B-cell NHL

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 26-Hag-2026 · NCT07691606

AutologousCD22 Chimeric Antigen Receptor (CAR)T Cells in w/Recurrent/Refractory B Cell Lymphomas

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 12-Hag-2026 · NCT06340737

Cosibelimab for CSCC in Patients With Kidney Transplant or Hematologic Malignancy

Namoota walitti qabaa jiraSadarkaa 4
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 11-Hag-2026 · NCT07426484

Observational Study Evaluating the Efficacy and Safety of Zanubrutinib in Participants With Waldenström Macroglobulinemia

Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Hag-2026 · NCT05640102

A Study of Lonitoclax (ZE50-0134) in Relapsed or Refractory B-cell Malignancies

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 31-Ado-2026 · NCT06708897

A Study of APG-3288 in Relapsed/Refractory Blood Cancers

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 30-Ado-2026 · NCT07424833

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 02-Ado-2026 · NCT05131022

Combating Cancer-Related Fatigue: A Personalized Supportive Care Program

Namoota walitti qabaa jira
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 01-Ado-2026 · NCT06860880

Registry of Older Patients With Cancer

Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 65 fi ol · Saalaa hunda · Haaromfame 29-Wax-2026 · NCT01137825

Study of MGUS, Smoldering Myeloma, Early MDS and CLL to Assess Molecular Events of Progression and Clinical Outcome

Namoota walitti qabaa jiraQorannoo ilaalaa
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 07-Cam-2026 · NCT02269592

SynKIR-310 for Relapsed/Refractory B-NHL

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 14-Elb-2026 · NCT06544265

A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 20-Bit-2026 · NCT04830137

Epcoritamab in Previously Treated WM

Namoota walitti qabaa jiraSadarkaa 2
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Bit-2026 · NCT06510491

Study of Oral Administration of LP-168 in Patients With Relapsed or Refractory B-cell Malignancies.

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Gur-2026 · NCT04775745

Study of SGR-1505 in Mature B-Cell Neoplasms

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 13-Gur-2026 · NCT05544019

AS-1763 in Patients With Previously Treated CLL/SLL or Non-Hodgkin Lymphoma

Namoota walitti qabaa jiraSadarkaa 1
Umuriin 18 fi ol · Saalaa hunda · Haaromfame 10-Mud-2025 · NCT05602363

Kanneen ClinicalTrials.gov irraa argaman, daataa 06-Onk-2026 irratti argame. Qorannoon hundi isaa kan ofii qajeelfama qoodfannaa qaba; gareen qorannoo eenyu akka hirmaatu murteessa.